Rachel F. Tyndale - Concepedia

Author

Rachel F. Tyndale

Also Known As

Dorret I. Boomsma, Joanne Knight, Lessov, Christina N., R F Tyndale, R TYNDALE, R Tyndale, R. F. Tyndale, R. Tyndale, R.F. Tyndale, RACHEL F. TYNDALE

576

Publications

25.6K

Citations

H-Index

216

Concepts

All Affiliations

University of Toronto Centre for Addiction and Mental Health University of California, San Francisco University of Pennsylvania Canada Research Chairs

About

Rachel F. Tyndale is an author at University of Toronto specializing in medicine, pharmacology, and addiction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	109	6.8K
2	Health Sciences	21	29	1.9K
3	Natural Sciences	3	3	309
4	Engineering	2	2	38
5	Language Studies	1	1	56

Rachel F. Tyndale

312

Publications

18.1K

Citations

H-Index

Page 1

	Year	Citations
Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver Toshifumi Aoyama, Saki Yamano, David J. Waxman, Journal of Biological Chemistry	1989	481
A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes E.S. Messina, Rachel F. Tyndale, Edward M. Sellers Journal of Pharmacology and Experimental Therapeutics	1997	452
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process Kelly E. Caudle, Teri E. Klein, James M. Hoffman, Current Drug Metabolism Genetic EpidemiologyPharmacotherapyGenetic MedicineGenotype-based Drug GuidelinesPharmacogenomics	2014	423
Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians Kerri A. Schoedel, Ewa Hoffmann, Yushu Rao, Pharmacogenetics Tobacco CessationTobacco ControlEthnic VariationSlow Nicotine MetabolismAdult Caucasians	2004	315
Nicotine without smoke: Tobacco harm reduction Amanda Amos, Deborah Arnott, Paul Aveyard, Tobacco CessationTobacco ControlSubstance AbuseHealth SciencesTobacco Use	2016	314
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial Caryn Lerman, Robert A. Schnoll, Larry W. Hawk, The Lancet Respiratory Medicine Tobacco CessationTobacco ControlTobacco UseAddictionNicotine	2015	292
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation Caryn Lerman, Rachel F. Tyndale, Freda Patterson, Clinical Pharmacology & Therapeutics	2006	273
Nicotine-dependence symptoms are associated with smoking frequency in adolescents Jennifer O’Loughlin, Joseph R. DiFranza, Rachel F. Tyndale, American Journal of Preventive Medicine Tobacco ControlSubstance AbuseSubstance UsePsychiatryNicotine-dependence Symptoms	2003	250
Inhibition of Cytochromes P450 by Antifungal Imidazole Derivatives Wenjiang Zhang, Yamini Ramamoorthy, Tansel Kilicarslan, Drug Metabolism and Disposition	2002	244
Duplications and Defects in the<i>CYP2A6</i>Gene: Identification, Genotyping, and In Vivo Effects on Smoking Yushu Rao, Ewa Hoffmann, Mohammad I. Zia, Molecular Pharmacology	2000	229

Page 1